Although surgical procedures on dialysis or transplant patients have become commonplace, changing concepts in this rapidly advancing field are well worth noting. It is not so long ago, for instance, that we assiduously avoided transfusing transplant candidates or stopped betaadrenergic blocking agents several days before surgery. But medical practices and conditions vary from country to country, and the nephrologist cannot be guaranteed the presence of an experienced anestresiologist in all circumstances, In the United States the distribution of anesthesiologists tends to follow economic and climatic patterns. When optimal personnel and equipment are not available, the nephrologist must decide whether to refer his patient to a larger center or treat him locally.
The dialysis patient receiving an anesthetic remains subject to hazards not shared by his fellow patients. Of these, hyperkalemia is the most dangerous (1), and should be corrected by dialysis before elective surgery or, in emergencies, with calcium gluconate, sodium bicarbonate, glucose and insulin, and exchange resins. During surgery, careful monitoring for EKG abnormalities is essential. Hypoventilation, metabolic acidosis and succinylcholine increase the danger of hyperkalemia and cardiac arrythmias. Acidosis should be corrected preoperatively.
If necessary THAM® (trihydroxyaminomethane) may be used to correct metabolic acidosis. Care must be taken to maintain ventilation if an overdose is given. Weintraub (2) has noted that succinylcholine increased serum potassium by an average of 0.55 meq/L.
Whenever possible the patient should be dialyzed 24 hours before elective procedures to correct acidosis, hyperkalemia, other electrolyte disturbances, volume overload, hypertension, and platelet dysfunction. Heparin used in hemodialysis will have been metabolized in 24 hours, but in emergencies protamine may be given to neutralize the heparin. Dialysis should usually be carried out within 24-36 hours post-operatively because of tissue sive. Unfortunately, it is not potent enough to produce full surgical anesthesia without supplementation with another anesthetic. Cyclopropane is highly explosive and rarely used since the advent of nonexplosive halogenated hydrocarbon anesthetics. The anesthesiologist should use the agent with which he is most familar. The time to experiment or learn something new is not in the middle of the night on a very ill patient.
Various combinations of drugs are used in conjunction with nitrous oxide and oxygen. This technique was introduced after Wolrd War II, especially in Liverpool, where large doses of curare were employed. Various combinations have received different appellations, a current popular term being neurolept anesthesia (or analgesia). In this a narcotic and an ataractic drug are used together. About 20 years ago this was called a «lytic cocktail». Trudnowski (5) has proposed neuroleptanalgesia as the anesthetic method of choice in uremic patients especially when supplemented with nitrous oxide.
Of the various muscle relaxants, gallamine and decamethonium are completely excreted by the kidney and are therefore contraindicated in uremic patients. Succinylcholine, as stated previously, increases serum potassium and is contraindicated in uremic patients who go to surgery with elevated serum potassium levels, because of the risk of cardiac arrythmias. Succinylcholine produces depolarization of cell membranes, leading to potassium loss from the cell and increased serum potassium. It is hydrolyzed by pseudocholinesterase, which is decreased in renal failure (6) , and although prolonged apnea would be expected following its use in uremia, this has only rarely been reported, probably because of its short duration of action. Although succinylcholine has been used in uremic patients with success, the danger and risk of hyperkalemia must be remembered. Dtubocurare has been used extensively in uremic patients even though 75% of the drug in normal patients is excreted by the kidneys. Prolonged neuromuscu lar blockade in renal failure is uncommon but has been reported (7). Liver excretion of D-tubocurare is increased in renal failure as is the volume of distribution of D-tubocurare. Pancuronium is also dependent on renal excretion. However those who like pancuronium use small doses in renal failure and have reported success with their technique. If muscle relaxants are administered, a nerve stimulator should be used to follow the twitch response to assess the effects of neuromuscular blockade. Monitoring the degree of neuromuscular blockade into the postanesthetic period will detect the prolongation or inadequate reversal of the effect. Pyridostigmine (7) should probably be used in place of neostigmine for terminating the muscle blockade of D-tubocurare or pancuronium in renal failure, because of its longer duration of action in catabolism and the danger of rapidly rising urea and potassium levels. Adequate preoperative control of blood pressure by dialysis or medication will decrease the risk of myocardial ischemia (3).
Anemia is generally well tolerated in dialysis patients because of increased cardiac output and elevated erythrocytes levels of 2,3 -diphosphoglycerate (DPG). Dialysis patients have undergone general anesthesia and major surgery with low hematocrits without incident. During surgery, the oxygen saturation should be maintained above 95%.
Epidural, spinal, and regional anesthesia can be comfortable and safe for the dialysis patient. However extradural hematoma with nerve root compression may occur in both epidural and spinal anesthesia if heparin is still present from recent hemodialysis or if uremic platelet dysfunction has not been corrected by dialysis. The epidural or spinal technique is very useful for renal transplant procedures as there is less of a chance of injurying the airway in patients on immunosuppressive therapy. There is a variety of opinions as to the local anesthetic of choice. 2-chloroprocaine is rapidly metabolized and is a safe pharmaceutical in the renal failure patient. Bupivacaine is long acting and affords very good analgesia. It may prove to be the «coming» drug in renal failure patients, as it provides prolonged analgesia in normal patients. It should be remembered that if spinal analgesia is employed the blood volume must be near normal, or hypotension may occur as the capacity of the vessels increases.
One advantage of using inhalation anesthetics is that what goes in through the lungs is eliminated through the lungs, and the patients can be ventilated post-operatively until complete recovery from the anesthetic occurs. All the inhalation anesthetics have been used in dialysis patients, and at various times each has been proposed as the drug of choice. If a fluorinated anesthetic is used, the choice should favor one with permanent bonding of the fluorine atom in renal transplant patients or umeric patients with some residual renal function. At present isoflurane appears to be the drug which undergoes least degradation to free fluorine. Halothane also has a fairly stable molecule. Enflurane is somewhat less stable, and methoxyflurane has dropped in popularity because patients have developed high output renal failure following prolonged anesthesia (4). Trichloroethylene has never been popular in the United States and has now been «outlawed» by the Food and Drug Administration because it was shown to cause cancer in animals. It is still used in India and other countries, and provides good analgesia. Ether, though rarely administered in North America, is used throughout the rest of the world with great safety. Nitrous oxide has little depressant effect on circulation, liver function, renal function and is not explo-renal failure and therefore reduced risk of recurarization. Neuromuscular blockade can be potentiated by certain antibiotics (streptomycin, neomycin, polymyxin A&B, gentamycin, kanamycin, colistin, and lincomycin).
Renal patients often have other diseases and frequently take a whole array of drugs. Brittle diabetics may present a difficult management problem, and the nephrologist, with the aid of the anesthesiologist, must exert his influence (or charm) to see that these patients are scheduled first in the morning. Insulin requirements must be determined, and a simple satisfactory method is giving half the usual dose in the morning and the rest according to a sliding scale based on blood sugars throughout the rest of the day. One must always bear in mind the possibility of adverse drug interactions. Cimetidine, for instance, prolongs the half-life of diazepam by 50% (8) . Antibiotics may interract with muscle relaxants given in the operating room. Infection is an ever-present threat, particularly in the immunosuppressed patient, and many anesthesiologists favor usigng a freshly cleaned anesthesia machine with aseptic valves, new tubing, and new carbon dioxide absorbent. It also goes without saying that a blood-pressure cuff should never be placed on the shunt or fistula arm, and that the advantages of inserting direct arterial lines should be weighed against the risk of infection and the potential loss of future access sites.
In the severely ill patient, a preoperative conference between anesthesiologist and the nephrologist may usefully address issues such as the timing of dialysis, the regulation of the blood volume, the type of fluids to be given, the prevention of hyperkalemia or bleeding problems, the use of albumin or other plasma expanders, and preoperative steroid regimens. This is also the time to review the drugs the patients may have been taking. At one time anesthesiologists would not give an anesthetic to a patient receiving tricyclic antidepressants; now most will proceed cautiously. Patients receiving tricyclics should not be given meperidine. Monoamine oxidase inhibitors are fortunately rarely used, but are quite dangerous, and constitute an indication for delaying elective operations by 7-10 days. Many of these decisions are best made within the context of an experienced team, if these chronically ill patients are to receive optimal care.
